游离脂肪酸受体4(FFAR4)被Gαq激活后,通过破坏Nr1h3-PPARγ轴来抑制代谢功能障碍。
Gαq activation of free fatty acid receptor 4 suppresses metabolic dysfunction by disrupting Nr1h3-PPARγ axis
Kong Yulin, Wang Jixia, Wang Zhen, Yang Shuting, Ye Xianlong, Wang Wei, Wang Hui, Deng Wanjun, Liu Yanfang, Xu Fangfang, Hou Tao, Zhao Yaopeng, Zhang Binyu, Yu Xuekui, Chen Yongquan, Liang Xinmiao, Z
Journal:Nature Communications
IF:18.1
DOI:10.1038/s41467-026-75589-2
PMID:42457710
Published:2026-07-15
research field:分子生物学生物信息学心脏病学生物标志物呼吸医学无创诊断
Abstract
Maintenance of glucose and lipid homeostasis is essential for metabolic health, and its dysregulation, driven by complex gene-environment interactions-underlies various metabolic disorders. Free fatty acid receptor 4 (FFAR4) has been proposed to link dietary signals with genetic metabolic predisposition, yet the precise mechanisms underlying the pathophysiological function of FFAR4 remain elusive and lack of the highly selective FFAR4 agonists. Our study shed light on the pivotal role of FFAR4 in metabolic homeostasis within metabolic organs. Hepatic FFAR4 deficiency in mice exacerbates lipid accumulation and promoted severe steatosis, whereas its overexpression ameliorates diet-induced metabolic dysfunction. Mechanistically, suppression of hepatic FFAR4 promotes lipogenesis by enhancing co-activation of the nuclear receptor Nr1h3 and PPARγ. Furthermore, we identify bavachalcone, a non-carboxylated compound isolated from the traditional Chinese medicine Psoralea corylifolia L ., as a functionally effective FFAR4 agonist, which could robustly attenuate metabolic dysfunction. Structural analysis using cryo-electron microscopy reveals the binding mode of bavachalcone within the FFAR4-Gα iq complex and illuminated the underlying mechanisms. In conclusion, our findings highlight an indispensable role of hepatic FFAR4 in counteracting metabolic dysregulation and identify bavachalcone as a selective and translatable FFAR4 agonist worthy of further clinical evaluation.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


